Clinical Trials Browser

Phase 1/2 × NIH × eribulin × Clear all

NCT04345913 2026-05-27

Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer

Phase 1/2 Active not recruiting

24 enrolled 24 charts

Triple Negative Breast Neoplasms

NCT00365157 2025-07-11

Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction

Phase 1/2 Active not recruiting

Carcinoma, Transitional Cell